{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T19:35:39Z","timestamp":1772652939228,"version":"3.50.1"},"reference-count":30,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2026,2,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Acute hepatitis C (AHC) has emerged as a relevant sexually transmitted infection (STI) among men who have sex with men (MSM), particularly linked to condomless anal practices and chemsex. Data on AHC in HIV pre-exposure prophylaxis (PrEP) users in our setting are scarce.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a descriptive case series study of AHC events identified within a PrEP user cohort followed between November 2019 and February 2025 at Hospital Cl\u00ednic de Barcelona. Cases of AHC were identified, and their socio-demographic, clinical and behavioural profiles were described.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 2003 individuals were enrolled in the PrEP programme during this period. The cohort was predominantly composed of cisgender MSM (96%), with a median age of 32 years, and 46% were born in Spain. Regarding sexual practices and substance use, 59% reported drug use, 82% of whom practised chemsex. Additionally, group sex and condomless anal sex were reported in 59% and 61% of participants, respectively. At baseline, 26% of patients tested positive for\n                      <jats:italic>Chlamydia trachomatis<\/jats:italic>\n                      (CT) or\n                      <jats:italic>Neisseria gonorrhoeae<\/jats:italic>\n                      (NG). Seven individuals (0.35%) had hepatitis C virus (HCV)-antibody positive with undetectable viraemia.\n                    <\/jats:p>\n                    <jats:p>\n                      During follow-up, 11 cases of AHC were diagnosed, yielding an incidence of 0.34 cases per 100 person-years (95% CI 0.17 to 0.61). All cases occurred in cisgender MSM, of whom 75% reported chemsex, 80% condomless group sex and 1 injecting drug use. STI coinfection was observed in 73% of AHC cases: 4 CT, 3\u2009NG and 2\n                      <jats:italic>Treponema pallidum<\/jats:italic>\n                      . Antiviral HCV treatment was effective in all cases, with no reinfections reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The incidence of AHC among PrEP users is not negligible and most cases reported substance use and sexual practices such as condomless sex and group sex. These findings highlight the need to reinforce systematic screening in this key population and adopt a multidisciplinary approach for an effective response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/sextrans-2025-056795","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T18:25:20Z","timestamp":1772648720000},"page":"sextrans-2025-056795","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Case series of hepatitis C virus infection among HIV pre-exposure prophylaxis (PrEP) users: incidence and behavioural characteristics"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6115-0116","authenticated-orcid":false,"given":"Kathereen Lizeth","family":"Rodr\u00edguez Sauceda","sequence":"first","affiliation":[{"name":"HIV Unit, Infectious Diseases Department, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6798-1718","authenticated-orcid":false,"given":"Nicol\u00e1s","family":"de Loredo","sequence":"additional","affiliation":[{"name":"HIV Unit, Infectious Diseases Department, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"},{"name":"Faculty of Medicine, University of Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4097-4996","authenticated-orcid":false,"given":"Francisco Jos\u00e9","family":"Montoya Conesa","sequence":"additional","affiliation":[{"name":"HIV Unit, Infectious Diseases Department, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"},{"name":"Faculty of Medicine, University of Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1957-5691","authenticated-orcid":false,"given":"Mar\u00eda Jos\u00e9","family":"Rodr\u00edguez Ruiz","sequence":"additional","affiliation":[{"name":"HIV Unit, Infectious Diseases Department, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2614-6545","authenticated-orcid":false,"given":"Elisa","family":"De Lazzari","sequence":"additional","affiliation":[{"name":"HIV Unit, Infectious Diseases Department, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"},{"name":"Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7798-6352","authenticated-orcid":false,"given":"Montserrat","family":"Laguno Centeno","sequence":"additional","affiliation":[{"name":"HIV Unit, Infectious Diseases Department, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"},{"name":"Faculty of Medicine, University of Barcelona, Barcelona, Spain"},{"name":"Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"2026030410251461000_sextrans-2025-056795v1.1","doi-asserted-by":"crossref","first-page":"101596","DOI":"10.1016\/j.clinre.2020.101596","article-title":"Epidemiology of hepatitis C virus infection","volume":"45","author":"Roudot-Thoraval","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2026030410251461000_sextrans-2025-056795v1.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.04150.x"},{"key":"2026030410251461000_sextrans-2025-056795v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2012.08.011"},{"key":"2026030410251461000_sextrans-2025-056795v1.4","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000126"},{"key":"2026030410251461000_sextrans-2025-056795v1.5","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001718"},{"key":"2026030410251461000_sextrans-2025-056795v1.6","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-018-2252-9"},{"key":"2026030410251461000_sextrans-2025-056795v1.7","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003837"},{"key":"2026030410251461000_sextrans-2025-056795v1.8","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2024-056169"},{"key":"2026030410251461000_sextrans-2025-056795v1.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.03.006"},{"key":"2026030410251461000_sextrans-2025-056795v1.10","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/cid\/ciac231","article-title":"Low prior exposure and incidence of hepatitis C in HIV-negative gay and bisexual men taking PrEP: findings from the Expanded PrEP Implementation in Communities-New South Wales study","volume":"75","author":"Amin","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2026030410251461000_sextrans-2025-056795v1.11","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/QAI.0000000000002685","article-title":"Brief Report: Low Incidence of Hepatitis C Among a Cohort of HIV-Negative Gay and Bisexual Men Using HIV Pre-exposure Prophylaxis (PrEP) in Melbourne, Australia, and the Contribution of Sexual Transmission","volume":"87","author":"Cornelisse","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026030410251461000_sextrans-2025-056795v1.12","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jfma.2025.06.021","article-title":"Prevalent and incident hepatitis C virus infections among participants in a pre-exposure prophylaxis program in Taiwan","volume":"124","author":"Huang","year":"2025","journal-title":"J Formos Med Assoc"},{"key":"2026030410251461000_sextrans-2025-056795v1.13","doi-asserted-by":"crossref","unstructured":"Cotte L , Cua E , Reynes J , et al . Hepatitis C virus incidence in HIV-infected and in PrEP-using men who have sex with men. Liver Int 2018. doi:10.1111\/liv.13922","DOI":"10.1111\/liv.13922"},{"key":"2026030410251461000_sextrans-2025-056795v1.14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/jvh.13678","article-title":"Low incidence and prevalence of hepatitis C in two cohorts of HIV pre-exposure prophylaxis adherence interventions in men who have sex with men in Southern California","volume":"29","author":"Hassan","year":"2022","journal-title":"J Viral Hepat"},{"key":"2026030410251461000_sextrans-2025-056795v1.15","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad401","article-title":"Incidence and Prevalence of Hepatitis C Virus Among HIV-Negative Gay and Bisexual Men Using HIV Pre-exposure Prophylaxis (PrEP): A Systematic Review and Meta-analysis","volume":"10","author":"Traeger","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026030410251461000_sextrans-2025-056795v1.16","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/jvh.13286","article-title":"Transmission of hepatitis C virus in HIV-positive and PrEP-using MSM in England","volume":"27","author":"Bradshaw","year":"2020","journal-title":"J Viral Hepat"},{"key":"2026030410251461000_sextrans-2025-056795v1.17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245925","article-title":"Low use of condom and high STI incidence among men who have sex with men in PrEP programs","volume":"16","author":"Ayerdi Aguirrebengoa","year":"2021","journal-title":"PLoS One"},{"key":"2026030410251461000_sextrans-2025-056795v1.18","first-page":"24","article-title":"PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement","volume":"41","author":"Laguno","year":"2023","journal-title":"Enfermedades Infecciosas y Microbiologia Clinica (English Ed)"},{"key":"2026030410251461000_sextrans-2025-056795v1.19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246129","article-title":"Implementation of pre-exposure prophylaxis programme in Spain. Feasibility of four different delivery models","volume":"16","author":"Iniesta","year":"2021","journal-title":"PLoS One"},{"key":"2026030410251461000_sextrans-2025-056795v1.20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s40121-022-00733-6","article-title":"Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years\u2019 Experience","volume":"12","author":"Ugarte","year":"2023","journal-title":"Infect Dis Ther"},{"key":"2026030410251461000_sextrans-2025-056795v1.21","unstructured":"Unidad de vigilancia de VIH, ITS y hepatitis virales y tuberculosis, Centro Nacional de Epidemiolog\u00eda, Instituto de Salud Carlos III . Vigilancia epidemiol\u00f3gica de la hepatitis c en espa\u00f1a 2022. Madrid: ISCIII; 2024. Available: https:\/\/cne.isciii.es\/documents\/d\/cne\/vigilancia_hepatitisc_2022"},{"key":"2026030410251461000_sextrans-2025-056795v1.22","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001522"},{"key":"2026030410251461000_sextrans-2025-056795v1.23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/QAD.0000000000002364","article-title":"Early diagnosis and risk factors of acute hepatitis C in high-risk MSM on preexposure prophylaxis","volume":"34","author":"Gras","year":"2020","journal-title":"AIDS"},{"key":"2026030410251461000_sextrans-2025-056795v1.24","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf014","article-title":"Hepatitis C Virus Seroprevalence, Incidence, and Screening Patterns in Ontario Preexposure Prophylaxis Users","volume":"12","author":"McGarrity","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"2026030410251461000_sextrans-2025-056795v1.25","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2005.018366"},{"key":"2026030410251461000_sextrans-2025-056795v1.26","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofv115","article-title":"Risk factors for sexual transmission of HCV among HIV-infected MSM: a case-control study","volume":"2","author":"Vanhommerig","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"2026030410251461000_sextrans-2025-056795v1.27","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3281053a0c"},{"key":"2026030410251461000_sextrans-2025-056795v1.28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.eimc.2014.05.013","article-title":"Brote epid\u00e9mico de hepatitis aguda C en pacientes infectados por el VIH","volume":"33","author":"Mart\u00ednez-Rebollar","year":"2015","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"2026030410251461000_sextrans-2025-056795v1.29","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-022-03730-5"},{"key":"2026030410251461000_sextrans-2025-056795v1.30","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s40121-021-00448-0","article-title":"Impact of Sexualized Substance Use and Other Risk Practices on HCV Microelimination in gbMSM Living with HIV: Urgent Need for Targeted Strategies. Results of a Retrospective Cohort Study","volume":"10","author":"Mart\u00ednez-Rebollar","year":"2021","journal-title":"Infect Dis Ther"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2025-056795","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T18:25:24Z","timestamp":1772648724000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2025-056795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":30,"alternative-id":["10.1136\/sextrans-2025-056795"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2025-056795","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]}}}